Patent assignee · US · COMPANY

Array BioPharma, Inc.

🏢 View company profile →
329Patents
302Active
329Granted
58Portfolio score

Filing activity: Oct 27, 1998 → Sep 3, 2024 · 87 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US7799782B2 P38 inhibitors and methods of use thereof Chemistry; Metallurgy 422 Active
US8933084B2 Macrocyclic compounds as Trk kinase inhibitors Emerging Cross-Sectional Technologies 80 Active
US8513263B2 Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitors Emerging Cross-Sectional Technologies 77 Active
US8791123B2 Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitors Emerging Cross-Sectional Technologies 68 Active
US8450322B2 Substituted imidazo[1,2b]pyridazine compounds as Trk kinase inhibitors Emerging Cross-Sectional Technologies 66 Active
US7169926B1 Dipeptidyl peptidase inhibitors Chemistry; Metallurgy 61 Expired
US8324221B2 Pyrimidyl cyclopentanes as Akt protein kinase inhibitors Chemistry; Metallurgy 53 Active
US9493476B2 Macrocyclic compounds as trk kinase inhibitors Emerging Cross-Sectional Technologies 43 Active
US8865698B2 Method of treatment using substituted pyrazolo[1,5-a]pyrimidine compounds Emerging Cross-Sectional Technologies 43 Active
US9127013B2 Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compounds Emerging Cross-Sectional Technologies 40 Active
US8063050B2 Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors Chemistry; Metallurgy 36 Active
US7235537B2 N3 alkylated benzimidazole derivatives as MEK inhibitors Chemistry; Metallurgy 30 Expired
US8003651B2 Pyrimidyl cyclopentanes as AKT protein kinase inhibitors Chemistry; Metallurgy 29 Active
US10208024B2 2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinases Physics 27 Active
US9682979B2 Substituted pyrazolo [1,5-A] pyrimidine compounds as TRK kinase inhibitors Emerging Cross-Sectional Technologies 25 Active
US10125134B2 KRas G12C inhibitors Chemistry; Metallurgy 25 Active
US9676783B2 Method of treatment using substituted pyrazolo[1,5-A] pyrimidine compounds Emerging Cross-Sectional Technologies 22 Active
US7732616B2 Dihydropyridine and dihydropyridazine derivatives as inhibitors of MEK and methods of use thereof Chemistry; Metallurgy 22 Active
US8648087B2 N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases Chemistry; Metallurgy 22 Active
US7449486B2 Mitotic kinesin inhibitors and methods of use thereof Chemistry; Metallurgy 22 Expired
US9718822B2 Macrocyclic compounds as Trk kinase inhibitors Emerging Cross-Sectional Technologies 22 Active
US9902741B2 Macrocyclic compounds as TRK kinase inhibitors Emerging Cross-Sectional Technologies 22 Active
US9840519B2 Macrocyclic compounds as TRK kinase inhibitors Emerging Cross-Sectional Technologies 21 Active
US9782414B2 Crystalline form of (S)-N-(5-((R)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-A]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide hydrogen sulfate Emerging Cross-Sectional Technologies 21 Active
US6362216B1 Compounds which inhibit tryptase activity Chemistry; Metallurgy 21 Expired

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.